Portfolio

Cell Therapeutics

Pharmaceutical company developing and commercializing an integrated portfolio of oncology products intended to make cancer more treatable


  • Seattle, WA
  • NASDAQ: CTIC

  • Contact:
    Marty Sutter
  • Exit date: May 17, 2005